Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.3390/cancers12010102

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorMolina Gallego, María Luisa-
dc.contributor.authorGarcía Bernal, David-
dc.contributor.authorMartínez Pérez, Salvador-
dc.contributor.authorValdor Alonso, Rut-
dc.contributor.otherFacultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Bioquímica y Biología Molecular B e Inmunología-
dc.date.accessioned2024-07-04T11:21:20Z-
dc.date.available2024-07-04T11:21:20Z-
dc.date.issued2019-12-31-
dc.identifier.citationCancers 2020, 12, 102-
dc.identifier.issnElectronic: 2072-6694-
dc.identifier.urihttp://hdl.handle.net/10201/142862-
dc.description© 2019 by the authors.This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/. This document is the Published version of a Published Work that appeared in final form in Cancer. To access the final edited and published work see https://doi.org/ doi:10.3390/cancers12010102-
dc.description.abstractGlioblastoma (GB) has been shown to up-regulate autophagy with anti- or pro-oncogenic effects. Recently, our group has shown how GB cells aberrantly up-regulate chaperone-mediated autophagy (CMA) in pericytes of peritumoral areas to modulate their immune function through cell-cell interaction and in the tumor’s own benefit. Thus, to understand GB progression, the effect that GB cells could have on autophagy of immune cells that surround the tumor needs to be deeply explored. In this review, we summarize all the latest evidence of several molecular and cellular immunosuppressive mechanisms in the perivascular tumor microenvironment. This immunosuppression has been reported to facilitate GB progression and may be differently modulated by several types of autophagy as a critical point to be considered for therapeutic interventions.es
dc.formatapplication/pdfes
dc.format.extent20es
dc.languageenges
dc.publisherMDPI-
dc.relationThis study was funded mainly by Ministerio de Economia y Competitividad de España, MINECO SAF2015-73923-JIN, Agencia Estatal de Investigación/Fondos Europeos de Desarrollo Regional/ Union Europea (AEI/FEDER/UE). It was supported in part by funds from Seneca Foundation 20840/PI/18, ISCIII/Red de Terapia Celular, TERCEL (RD16/0011/0010 and RD16/0011/0001).es
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAutophagyes
dc.subjectChaperone-mediated autophagyes
dc.subjectTumores
dc.subjectGlioblastomaes
dc.subjectPerivascular cellses
dc.subjectPericyteses
dc.subjectImmunosuppressivees
dc.subjectTumor immune tolerancees
dc.subjectAutophagy inhibitorses
dc.titleAutophagy in the immunosuppressive perivascular microenvironment of glioblastomaes
dc.typeinfo:eu-repo/semantics/articlees
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/12/01/102-
dc.identifier.doihttps://doi.org/10.3390/cancers12010102-
Aparece en las colecciones:Artículos: Bioquímica y Biología Molecular "B" e Inmunología

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
cancers-12-00102.pdf2,29 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons